Coya Therapeutics Inc (COYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 0 | 3,425 | 127 | 0 | 0 |
| Gross Profit | N/A | 3,425 | 127 | N/A | N/A |
| Operating Expenses | 4,450 | 6,661 | 5,610 | 4,187 | 3,564 |
| Operating Income | -4,450 | -3,236 | -5,483 | 1,815 | -3,564 |
| Other Income | 429 | 344 | 431 | 175 | 142 |
| Pre-tax Income | -4,021 | -2,892 | -5,052 | 1,990 | -3,422 |
| Net Income Continuous | -4,021 | -2,892 | -5,052 | 1,266 | -3,422 |
| Net Income | $-4,021 | $-2,892 | $-5,052 | $1,266 | $-3,422 |
| EPS Basic Total Ops | -0.26 | -0.19 | -0.35 | 0.14 | -0.34 |
| EPS Basic Continuous Ops | -0.26 | -0.19 | -0.35 | 0.15 | -0.34 |
| EPS Diluted Total Ops | -0.26 | -0.19 | -0.35 | 0.14 | -0.34 |
| EPS Diluted Continuous Ops | -0.26 | -0.19 | -0.35 | 0.15 | -0.34 |
| EPS Diluted Before Non-Recurring Items | -0.26 | -0.19 | -0.35 | 0.15 | -0.34 |
| EBITDA(a) | $-4,443 | $-3,229 | $-5,476 | $-4,180 | $-3,557 |